• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Expert Opinion on Therapeutic Patents >Anticancer patent landscape and technology assessment of Indian public-funded research institutes and organizations
【24h】

Anticancer patent landscape and technology assessment of Indian public-funded research institutes and organizations

机译：印度公立研究机构和组织的抗癌专利态势和技术评估

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Introduction: This review discusses the various drug therapeutic targets and latest technologies of anticancer patents from 10 Indian public-funded research organizations covering more than 150 esteemed institutes. We have identified and reported the leading assignee and inventors along with their collaboration network and, thereby, have analyzed the various patent trends, geographical distributions, citation maps, Derwent World Patents Index, international patent classification analysis and the like. Areas covered: This article provides the insights of 1905 patent documents from 191 families and discusses in-depth anticancer technology through categorization studies at the level of drug discovery, drug development and treatment and diagnosis. In addition, various cancer targets were correlated with recent technologies so as to identify the white spaces for upcoming technologies. Expert opinion: Over a period of 13 years (1990 - 2013) the main focus of Indian cancer research was in the field of synthetic chemistry and natural extracts followed by the pharmaceutical compositions and combinations, whereas, the white spaces for future cancer remedy were identified from research in the areas of cancer stem cell lines, vaccines, gene therapy, nano formulations with targeted drug delivery systems as core and latest technologies.
机译：简介：这篇综述讨论了来自印度的10家公共资助研究机构的各种药物治疗靶点和抗癌专利的最新技术，这些研究机构覆盖了150多家受人尊敬的机构。我们已经确定并报告了主要的受让人和发明人以及他们的合作网络，从而分析了各种专利趋势，地理分布，引文地图，德文特世界专利索引，国际专利分类分析等。涵盖的领域：本文提供了来自191个家族的1905年专利文件的见解，并通过在药物发现，药物开发以及治疗和诊断方面的分类研究来讨论了深入的抗癌技术。另外，各种癌症靶标与最新技术相关联，以便为即将到来的技术确定空白。专家意见：在过去的13年中（1990年至2013年），印度癌症研究的主要重点是合成化学和天然提取物领域，其次是药物组合物和组合，然而，确定了用于未来癌症治疗的空白来自癌症干细胞系，疫苗，基因疗法，以靶向药物递送系统为核心和最新技术的纳米制剂等领域的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号